A clinical trial to maintain glycemic control in youth with type 2 diabetes.
about
Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart AssociationEarly onset type 2 diabetes: risk factors, clinical impact and managementObesity and type 2 diabetes in children: epidemiology and treatmentCurrent treatment options for type 2 diabetes mellitus in youth: today's realities and lessons from the TODAY studyLifestyle therapy for the treatment of youth with type 2 diabetesType 2 diabetes mellitus in children and adolescents: a relatively new clinical problem within pediatric practiceDrug interventions for the treatment of obesity in children and adolescentsThe study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetesThe Efficacy and Safety of Chinese Herbal Medicine Jinlida as Add-On Medication in Type 2 Diabetes Patients Ineffectively Managed by Metformin Monotherapy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter TrialDietary Intervention for Glucose Tolerance In Teens (DIG IT): Protocol of a randomized controlled trial using health coaching to prevent youth-onset type 2 diabetesHeart disease and stroke statistics--2014 update: a report from the American Heart AssociationHeart Disease and Stroke Statistics-2017 Update: A Report From the American Heart AssociationDrugs for the treatment of pediatric type 2 diabetes mellitus and related co-morbidities.Metabolic basis of ethnic differences in diabetes risk in overweight and obese youth.Bariatric and Metabolic Surgery in Adolescents: a Path to Decrease Adult Cardiovascular Mortality.Restoring Insulin Secretion (RISE): design of studies of β-cell preservation in prediabetes and early type 2 diabetes across the life spanPathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.A cross-sectional view of the current state of treatment of youth with type 2 diabetes in the USA: enrollment data from the Pediatric Diabetes Consortium Type 2 Diabetes Registry.A Self-assessment Tool for Screening Young Adults at Risk of Type 2 Diabetes Using Strong Heart Family Study DataCardiometabolic risk factors, metabolic syndrome and pre-diabetes in adolescents in the Sierra region of Ecuador.Characteristics and cardiovascular complications of a large cohort of adults diagnosed with type 2 diabetes <45 years.Gaps and barriers in the control of blood glucose in people with type 2 diabetes.Retrospective Evaluation of Metformin and/or Metformin Plus a New Polysaccharide Complex in Treating Severe Hyperinsulinism and Insulin Resistance in Obese Children and Adolescents with Metabolic Syndrome.The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial.Comparing diabetes medications: where do we set the bar?Parenting style, parent-youth conflict, and medication adherence in youth with type 2 diabetes participating in an intensive lifestyle change intervention.Comparison of Antidiabetic Regimens in Patients with Type 2 Diabetes Uncontrolled by Combination Therapy of Sulfonylurea and Metformin: Results of the MOHAS Disease Registry in Korea.Nephropathy in youth and young adults with type 2 diabetesAlterations in left ventricular, left atrial, and right ventricular structure and function to cardiovascular risk factors in adolescents with type 2 diabetes participating in the TODAY clinical trial.Metformin pharmacogenomics: current status and future directions.Addressing prediabetes in childhood obesity treatment programs: support from research and current practice.Design, implementation, and evaluation of a pediatric and adolescent type 2 diabetes management program at a tertiary pediatric center.Relationships among stressful life events and physiological markers, treatment adherence, and psychosocial functioning among youth with type 2 diabetesChallenging recruitment of youth with type 2 diabetes into clinical trials.Early-onset type 2 diabetes impairs skeletal acquisition in the male TALLYHO/JngJ mouse"We are all gonna get diabetic these days": the impact of a living legacy of type 2 diabetes on Hispanic young adults' diabetes care.We can change the natural history of type 2 diabetes.Liraglutide's safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: a randomized, double-blind, placebo-controlled trial.Treatment outcomes of overweight children and parents in the medical home.Emerging gliptins for type 2 diabetes.
P2860
Q22306356-F6BFA04F-C9E9-41A3-8FCA-B5D9AA923885Q26824144-1695241C-C03B-4288-9678-BD3512E1860FQ26830006-C34C3C36-90C5-4D2A-BEF2-3C311DBE798AQ26863463-23C21BD1-27A3-4D66-B5DD-D496EECACDE4Q26995151-F91A55C5-0CE1-4A7F-B2C9-7EE15CD2B2EAQ28077057-BB88EA4B-0313-4CC8-AF93-E8A93376AF15Q28279770-9EEE85CD-828D-4418-BF57-D85425075CB7Q28545045-89D79BE5-4653-4DF4-B830-B578EA4B1295Q28548552-C5BF66A6-0860-481D-8607-E06E0FA8DFF2Q29048629-C3BFC250-069A-44D9-A3AF-3C2F942F795AQ29547691-1DA77521-315B-4BCA-AF94-9A46CD161C22Q30238784-D1A065D5-C4D5-4C17-9C32-587DC80DB8B8Q30241716-857A5094-BFF7-43C5-8D5C-D0101EB0C899Q30358115-8EC52F8A-55D1-405E-9881-C42A76990BD1Q30377144-05A792A9-A80F-42CD-9721-25DB2546EA1AQ30572405-2EF40C42-9475-4CD4-9E28-468A4274A02FQ30597265-CD661E0A-02E5-42C0-B6F7-22B27462440DQ31057431-4906F847-44E6-4FBD-A017-2E0A63C5824DQ31118956-6894F796-C09F-482A-A0DA-BCF587911169Q33582590-CB9A79D7-95D4-4AD2-82A7-C5AD7EA9B22EQ33629608-05FFC8EC-0499-4EEE-850F-23C04246BDB5Q33641379-4DE2B424-D7A1-43EF-BA9F-F0231D277409Q33749648-A653048F-7EB3-4A92-9730-BB53FF441FFDQ33750231-5B9DA6B6-04A7-45B2-80A6-D213B0936B49Q33764404-C43FE0C7-CA48-48BF-A9C8-73740F37C5FEQ33801068-8B5EB0E1-8B64-4802-802A-B5F13F5A15A6Q33849111-5F35A924-24C2-4AD4-BD75-683F64031DBFQ33903763-F9E7175C-1E76-4459-B5E5-E15FA5B76B18Q33935078-1541655B-67CF-4195-BAF2-78C0EFCCAC85Q33959731-83C48DE4-BF34-4117-922B-630485929466Q33998049-7A8C4A85-039B-4EF3-AB64-D8907AF180BCQ34011958-79662564-F408-4F8E-AFD8-DA62A3A3FAC6Q34090482-75E2F96C-AD2C-4666-9ED4-A26FC5D079C6Q34180348-9718D1B2-FF73-41C8-A7C5-8B1B68EB71C1Q34185713-2527662E-5481-49BC-B7A4-5AA2635F6A7EQ34214446-7C4949B9-DEB9-4E65-8BE8-DA6D6B7F2DCDQ34219402-FD9D9442-0BB8-4639-93E2-3752C0B6BFCEQ34284003-6103482F-37D2-403F-815F-E9D307414BEFQ34296029-3C5940A5-7B52-4E4A-85EB-8F54283A488CQ34347884-84C2269D-CEE9-4426-B925-91F230CF8162
P2860
A clinical trial to maintain glycemic control in youth with type 2 diabetes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
A clinical trial to maintain glycemic control in youth with type 2 diabetes.
@ast
A clinical trial to maintain glycemic control in youth with type 2 diabetes.
@en
type
label
A clinical trial to maintain glycemic control in youth with type 2 diabetes.
@ast
A clinical trial to maintain glycemic control in youth with type 2 diabetes.
@en
prefLabel
A clinical trial to maintain glycemic control in youth with type 2 diabetes.
@ast
A clinical trial to maintain glycemic control in youth with type 2 diabetes.
@en
P2093
P2860
P356
P1476
A clinical trial to maintain glycemic control in youth with type 2 diabetes.
@en
P2093
Barbara Linder
David M Nathan
Denise Wilfley
Francine Kaufman
Kathryn Hirst
Kenneth Copeland
Laura Pyle
Leona Cuttler
Phil Zeitler
Sherida Tollefsen
P2860
P304
P356
10.1056/NEJMOA1109333
P407
P577
2012-04-29T00:00:00Z